Johnson & Johnson (JNJ) : Cornerstone Capital Management Holdings. reduced its stake in Johnson & Johnson by 5.4% during the most recent quarter end. The investment management company now holds a total of 1,081,091 shares of Johnson & Johnson which is valued at $122.8 Million after selling 61,747 shares in Johnson & Johnson , the firm said in a disclosure report filed with the SEC on May 11, 2016.Johnson & Johnson makes up approximately 1.03% of Cornerstone Capital Management Holdings.’s portfolio.
Other Hedge Funds, Including , Ipswich Investment Management reduced its stake in JNJ by selling 1,399 shares or 2.36% in the most recent quarter. The Hedge Fund company now holds 57,871 shares of JNJ which is valued at $6.6 Million. Johnson & Johnson makes up approx 3.17% of Ipswich Investment Management’s portfolio.Morgan Dempsey Capital Management boosted its stake in JNJ in the latest quarter, The investment management firm added 2,259 additional shares and now holds a total of 16,916 shares of Johnson & Johnson which is valued at $1.9 Million. Johnson & Johnson makes up approx 0.70% of Morgan Dempsey Capital Management’s portfolio. Puplava Financial Services added JNJ to its portfolio by purchasing 2,141 company shares during the most recent quarter which is valued at $243,132. Johnson & Johnson makes up approx 0.15% of Puplava Financial Services’s portfolio.First Dallas Securities reduced its stake in JNJ by selling 3,494 shares or 9.01% in the most recent quarter. The Hedge Fund company now holds 35,295 shares of JNJ which is valued at $4 Million. Johnson & Johnson makes up approx 3.20% of First Dallas Securities’s portfolio. Efficient Market Advisors sold out all of its stake in JNJ during the most recent quarter. The investment firm sold 405 shares of JNJ which is valued $45,392.
Johnson & Johnson opened for trading at $113.39 and hit $114.63 on the upside on Monday, eventually ending the session at $114.44, with a gain of 0.77% or 0.88 points. The heightened volatility saw the trading volume jump to 62,22,861 shares. Company has a market cap of $314,784 M.
On the company’s financial health, Johnson & Johnson reported $1.68 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.65. The company had revenue of $17482.00 million for the quarter, compared to analysts expectations of $17491.02 million. The company’s revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.56 EPS.
Investors should note that on Apr 28, 2016, Johnson & Johnson announced a cash dividend of $0.8000. The company’s management has announced May 20, 2016 as the ex-dividend date and fixed the record date on May 24, 2016. The payable date has been fixed on Jun 7, 2016.
Many Wall Street Analysts have commented on Johnson & Johnson. Company shares were Reiterated by RBC Capital Mkts on Apr 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 125 from a previous price target of $122 .Company shares were Reiterated by Piper Jaffray on Apr 20, 2016 to “Neutral”, Firm has raised the Price Target to $ 106 from a previous price target of $105 .Company shares were Reiterated by RBC Capital Mkts on Apr 15, 2016 to “Outperform”, Firm has raised the Price Target to $ 122 from a previous price target of $114 .
Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.